July 24, 2019 | City of Hope
An study conducted by Michael Caligiuri, M.D., and Jianhua Yu, Ph.D., unveiled why anti-PD-L1 monoclonal antibodies (mAb) are still effective in fighting tumors that lack PD-L1 receptors on their cells.
City of Hope enrolling patients in clinical trial for HPV-linked cancers
August 20, 2019 | Letisia Marquez
A first-in-human, phase 1 T cell trial for patients who have human papillomavirus (HPV)-associated cancers that have relapsed, or are resistant to treatment, is now open at City of Hope. The institution is the first to open such a trial on the West Coast.
First in the nation: City of Hope to offer experimental T cell drug for liver cancer patients
August 5, 2019 | Zen Vuong
An ongoing clinical study in China on the drug showed liver tumor shrinkage, regression of metastatic tumors and fewer side effects than in other T cell clinical trials.
Leukemia patient finds donor halfway around the world
May 9, 2019 | Letisia Marquez
Acute myeloid leukemia patient Leif Voeltz's perfect match for a bone marrow transplant was located in Germany. Now Marcel Waldmann is traveling to the U.S. for the first time to meet the man whose life he saved.